NEJM (@nejm) 's Twitter Profile
NEJM

@nejm

The New England Journal of Medicine is the world’s leading medical journal and website.

ID: 25950355

linkhttp://NEJM.org calendar_today23-03-2009 04:10:07

32,32K Tweet

946,946K Followers

437 Following

NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

🗣️ New clinical trial: Compared to aspirin alone, rivaroxaban + aspirin significantly improves walking distance in high-risk patients with peripheral artery disease who have intermittent claudication. 1/2

🗣️ New clinical trial: Compared to aspirin alone, rivaroxaban + aspirin significantly improves walking distance in high-risk patients with peripheral artery disease who have intermittent claudication. 1/2
NEJM (@nejm) 's Twitter Profile Photo

In June 2024, the Supreme Court issued an order halting implementation of a regulation intended to limit the interstate spread of ozone-forming emissions. The decision could endanger human health. Read the full Perspective: nej.md/3AKxNZ2

In June 2024, the Supreme Court issued an order halting implementation of a regulation intended to limit the interstate spread of ozone-forming emissions. The decision could endanger human health. Read the full Perspective: nej.md/3AKxNZ2
NEJM (@nejm) 's Twitter Profile Photo

Institutional special-needs plans could warrant further investigation as a value-based model for financing care provided to long-stay nursing home residents. Read the full Perspective: nej.md/3AJlb4z

Institutional special-needs plans could warrant further investigation as a value-based model for financing care provided to long-stay nursing home residents. Read the full Perspective: nej.md/3AJlb4z
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma nej.md/3Xa9oDT Editorial: A Late-Arriving but Welcome Advance in Sarcoma Therapy nej.md/3z8Bibj #Oncology

Original Article: Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma nej.md/3Xa9oDT 

Editorial: A Late-Arriving but Welcome Advance in Sarcoma Therapy nej.md/3z8Bibj 

#Oncology